Tag: Gates Foundation
-
Lenacapavir PrEP Price Drop: From $28,000 to $40 Expands Access
What is Lenacapavir and how does it work as PrEP? Lenacapavir is a long-acting HIV prevention drug (PrEP) that is administered as an injection twice a year. In the European Union, it has been approved for preventive use under the brand name Yeytuo, with Gilead as the manufacturer. Early studies have shown near-total protection against…
-
Lenacapavir: HIV prevention price slashed for LMICs
What is Lenacapavir and why does it matter for HIV prevention? Lenacapavir, marketed under the brand name Yeytuo, is a long-acting HIV prevention treatment that is injected twice a year. The EU approval placed it among the few options designed to simplify and strengthen pre- exposure prophylaxis (PrEP) by reducing the burden of daily pills.…
-
HIV Prevention Breakthrough: Lenacapavir PrEP Price Drop Expands Global Access
Lenacapavir: A Breakthrough in HIV Prevention Lenacapavir, marketed as Yeytuo, has advanced HIV prevention by offering a long-acting injectable PrEP treatment. Unlike daily pills, it is given as an injection twice a year, a feature that could simplify adherence for many people at risk. In the European Union, lenacapavir has been approved as a preventive…